Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
749
Employees749
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
749
Employees749

NVAX Key Statistics

Market cap
1.26B
Market cap1.26B
Price-Earnings ratio
3.15
Price-Earnings ratio3.15
Dividend yield
Dividend yield
Average volume
4.07M
Average volume4.07M
High today
$7.91
High today$7.91
Low today
$7.57
Low today$7.57
Open price
$7.69
Open price$7.69
Volume
4.66M
Volume4.66M
52 Week high
$11.97
52 Week high$11.97
52 Week low
$5.01
52 Week low$5.01

Stock Snapshot

Novavax(NVAX) stock is priced at $7.75, giving the company a market capitalization of 1.26B. It carries a P/E multiple of 3.15.

On 2026-04-02, Novavax(NVAX) stock traded between a low of $7.57 and a high of $7.91. Shares are currently priced at $7.75, which is +2.4% above the low and -2.0% below the high.

Novavax(NVAX) shares are trading with a volume of 4.66M, against a daily average of 4.07M.

During the past year, Novavax(NVAX) stock moved between $5.01 at its lowest and $11.97 at its peak.

During the past year, Novavax(NVAX) stock moved between $5.01 at its lowest and $11.97 at its peak.

NVAX News

Simply Wall St 6h
Will Novavax’s New R&D Chief Reframe Its Partnership-Led Strategy and Long-Term Story?

Novavax recently appointed Dr. Robert Walker as Executive Vice President and Head of Research & Development, succeeding Dr. Ruxandra Draghia-Akli and placing hi...

Will Novavax’s New R&D Chief Reframe Its Partnership-Led Strategy and Long-Term Story?
Nasdaq 4d
Investors Heavily Search Novavax, Inc.: Here is What You Need to Know

Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the n...

Investors Heavily Search Novavax, Inc.: Here is What You Need to Know
Simply Wall St 5d
Evaluating Novavax Valuation As Licensing Deal And Recent Returns Shape Market Expectations

Advertisement Recent share performance and what it may signal for investors Novavax (NVAX) has seen mixed share performance recently, with a 5.6% decline over...

Evaluating Novavax Valuation As Licensing Deal And Recent Returns Shape Market Expectations

Analyst ratings

63%

of 8 ratings
Buy
62.5%
Hold
12.5%
Sell
25%

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.